InvestTech Analytics

AI in Pharma Investment Digest

AI for Drug Discovery, Biomarker Development and Advanced R&D in Asia

Investment Digest
60 Pages
Investment Digest banner.png
Investment Digest
Teaser
Investment Digest - Teaser.png
Investment Digest
One Pager
ffff-1.jpg

This Investment Digest is summarizing key players and observations in the private equity and venture capital ecosystem, focusing on the pharmaceutical Artificial Intelligence (AI).

 

Here we have presented the information about key industry trends, 240 promising AI-driven biotech startups, and 50 leading biotech investors in this sector, outlining major investment rounds and relevant R&D partnerships illustrating the industry traction and readiness of institutional investors (big pharma/biotech) to potentially acquire most successful AI-vendors.

AI in Pharma Investment Digest Asia

AI for Drug Discovery, Biomarker Development andAdvanced R&D in Asia

Investment Digest
50 Pages
banner asia.png
Investment Digest
Teaser
asia teaser.png
Investment Digest
One Pager
Asia Investment Digest.png

This Investment Digest is summarizing key players and observations in the private equity and venture capital ecosystem, focusing on the pharmaceutical Artificial Intelligence (AI) in Asia.

 

Here we have presented the information about key industry trends, 30 promising Asia-based AI-driven biotech startups, and 70 biotech investors in this sector, outlining major investment rounds and relevant R&D partnerships illustrating the industry traction and readiness of institutional investors (big pharma/biotech) to potentially acquire most successful AI-vendors.

Longevity Investment Digest

Overview of Longevity Industry in 2021

Investment Digest
145 Pages
1 inv.png
Investment Digest
Teaser
2 inv.png
Investment Digest
One Pager
inv 3.png

This Investment Digest is summarizing key observations in the private equity and venture capital ecosystem of the rapidly evolving and exponentially growing Longevity industry. Here we have presented the information about key industry trends, more than 20000 longevity companies, 50 leading investors in this sector, and more than 300 longevity-focused publicly traded corporations, outlining major investment rounds and relevant R&D trends illustrating the industry traction and readiness of institutional investors (including top-tier financial institutions) to potentially acquire most successful AgeTech, Longevity Fintech, and Longevity Biomedicine startups

NeuroTech Investment Digest

Global NeuroTech Industry Landscape Overviews

Investment Digest
55 Pages
NeuroTech Inv Digest.png
Investment Digest
Teaser
NeuroTech Inv Teaser.png
Investment Digest
One Pager
OnePager-Neurotech-Investment-Digest-2.jpg

Global NeuroTech Industry Landscape Overviews are reports of NeuroTech Analytics, the world’s premier source of NeuroTech Industry Analytics, Forecasting and Benchmarking and the central repository of market insights and trends and news for the NeuroTech space, including sectors, influences, investors, technologies, R&D centers, Hubs, companies and more.

AI in Pharma Publicly Traded Companies 2021 
Investment Digest

AI for Drug Discovery, Biomarker Development and Advanced R&D Publicly Traded Companies Overview 2021

Investment Digest
45 Pages
inv 7.png
Investment Digest
One Pager
inv 8.png

This Investment Digest is summarizing key players and observations in the stock market, focusing on the pharmaceutical Artificial Intelligence.


Here we have presented the information about key industry trends, 14 promising AI-driven publicly traded pharma companies, outlining major investment rounds and relevant R&D partnerships illustrating the industry traction and readiness of institutional investors (big pharma/biotech) to potentially acquire most successful AI-vendors, and conducted in-depth financial analysis of the AI in Pharma stock market, as well as presented our proprietary specialized thematic stock indices and porfolios.